Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

ACT Gets U.K. Go-Ahead to Start First Ever Non-U.S. Trial with hESC-Derived Cell Therapy

Study will evaluate firm’s retinal pigment cell therapy in Stargardt disease.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »